30,000 breast cancer patients tracked in Long-Term database study
NCT ID NCT02893761
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study collects and analyzes data from 30,000 breast cancer patients treated at Institut Bergonié since the 1990s. Researchers aim to track survival, assess treatment practices, and search for factors that predict outcomes. No new treatments are being tested; instead, the goal is to learn from past patient experiences.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- This database may help doctors better understand long-term outcomes and identify factors that influence breast cancer survival.
- What could go wrong
- This is an observational study, not a treatment trial. It cannot directly improve patient outcomes and may be limited by incomplete or outdated data.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Institut Bergonié, Comprehensive Cancer Center
RECRUITINGBordeaux, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?
- Radiation may let breast cancer patients keep their nipple
- Can a smart digital program restore sleep for cancer survivors?